New Delhi: Drug major Wockhardt is recalling over 8,000 bottles of anti-hypertension drug Metoprolol Succinate extended-release tablets in the US market following failure of a dissolution test. The recall is due to the “failure of dissolution test observed at three month time point”, USFDA said. The withdrawal was classified as a Class-II recall, which the FDA defines as “a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote”.
Wockhardt recalls hypertension drug
RECENT STORIES
Big Change In EPF Withdrawal Rules Coming, No Need to Wait for Retirement Anymore

Tech Mahindra Shares Fall Over 2% As Sequential Net Profit Slips Despite Strong YoY Growth

US President Donald Trump Unveils Plan For Unified Tariff On Over 150 Countries

Anand Mahindra Welcomes Elon Musk And Tesla To India, Says “See You At The Charging Station”

PM Kisan Big Alert: 20th Installment Of ₹2000 Coming, Just 1 Day Left To Complete Key Steps
